APOL1 and Chronic Kidney Disease: New Findings in African Populations
Rasheed A. Gbadegesin, MD, MBBS
PeerDiagnosing IgAN: The Importance of Early and Accurate Identification
James Chevalier, MD
PeerInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
John Sim, MD
PeerAchieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
Robin Dore, MD
PeerIgAN Explained: Key Differences from Other Kidney Conditions
Mohamed Ibrahim, MB, BCh
PeerMeasuring IgAN Risk: Genetic, Environmental, and Systemic Factors
Mohamed Ibrahim, MB, BCh
PeerThe Role of APRIL in IgA Nephropathy
Unraveling IgA Nephropathy Pathogenesis: APRIL and the Four-Hit Cascade
Unraveling IgA Nephropathy: Clinical Features and the Need for Early Diagnosis
Acute Kidney Injury in Sepsis and How We Can Predict It
Managing Lupus Nephritis: Multidisciplinary Insights on Recent Guideline Updates